Related Experiment Video
Updated: Mar 24, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C
Wan-Ting Yang1, Li-Wei Wu, Tai-Chung Tseng
1From the Division of Gastroenterology (T-CT, C-CW), Department of Internal Medicine, Taipei Tzuchi Hospital, The Buddhist Tzuchi Medical Foundation; Division of Gastroenterology (H-CY, T-HS, C-HL, P-JC, C-JL, J-HK), Department of Internal Medicine; Graduate Institute of Clinical Medicine (C-LC, T-HS, C-HL, C-JL, J-HK); Hepatitis Research Center (W-TY, C-HL, J-HK); Department of Medical Research (J-HK); Department of Microbiology (H-CY), National Taiwan University College of Medicine and National Taiwan University Hospital; Master of Public Health Degree Program (W-TY), National Taiwan University, Taipei; Division of Gastroenterology (L-WW), Department of Internal Medicine, Taipei Medical University-Shuang Ho Hospital, New Taipei; School of Medicine (T-CT, C-CW), Tzu Chi University, Hualien; Genomics Research Center Academia Sinica (D-SC), Taipei, Taiwan; St Vincent's Hospital (SF-TK), Melbourne VIC, Australia; and Taiwan Liver Disease Consortium (TLC) (C-JL), Taipei, Taiwan.
Insights
Hepatitis C virus (HCV) coinfection does not impact Hepatitis B virus (HBV) loss. Higher ALT levels predict HBV loss and increase hepatocellular carcinoma (HCC) risk in coinfected patients.
Area of Science:
- Hepatology
- Virology
- Clinical Medicine
Background:
- Hepatitis B virus (HBV) and hepatitis C virus (HCV) are leading causes of chronic viral hepatitis.
- The impact of HCV coinfection on HBV replication and patient outcomes remains unclear.
Purpose of the Study:
- To investigate the effect of HCV coinfection on HBV replication and clinical outcomes.
- To identify factors influencing HBsAg loss and hepatocellular carcinoma (HCC) development in HBV/HCV coinfected patients.
Main Methods:
- A 10-year longitudinal study comparing 111 HBV/HCV coinfected patients with 111 propensity score-matched HBV monoinfected controls.
- Analysis of host and viral factors, including alanine aminotransferase (ALT) levels, correlated with outcomes like HBsAg loss and HCC development.
Main Results:
- HCV coinfection was not associated with Hepatitis B surface antigen (HBsAg) loss.
- Patients with ALT levels >80 U/L had a significantly higher chance of HBsAg loss, irrespective of HCV coinfection.
- Both HCV coinfection and elevated ALT levels were independently associated with increased HCC risk, persisting even after HBsAg loss.
Conclusions:
- HCV coinfection does not influence HBsAg loss.
- Elevated ALT levels are a key determinant for HBsAg loss in coinfected individuals.
- HCV coinfection and higher ALT levels are independent risk factors for HCC development.
Abstract:
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are 2 major causes of chronic viral hepatitis. It is still unclear how HCV coinfection affects HBV replication and clinical outcomes in HBV/HCV coinfected patients.We conducted a longitudinal study, which enrolled 111 patients with HBV/HCV coinfection and 111 propensity score-matched controls with HBV monoinfection. Both groups had comparable baseline age, sex, fibrosis stage, levels of HBV DNA, and HBV surface antigen (HBsAg). The HCV coinfection and other host/viral factors were correlated with various outcomes, including HBsAg loss and cirrhosis/hepatocellular carcinoma (HCC) development.After a 10-year follow-up, we found that HCV coinfection itself was not associated with HBsAg loss. However, coinfected patients with alanine aminotransferase (ALT) level >80 U/L had a higher chance of HBsAg loss than those with ALT level ≤80 U/L [hazard ratio (95% confidence interval): 4.41 (1.75-11.15)] or matched controls with HBV monoinfection [hazard ratio (95% confidence interval): 3.40 (1.54-7.50)]. Besides, both HCV coinfection and higher ALT levels were associated with higher HCC risks and the HCC risks remained even after HBsAg loss in HBV/HCV con-infected patient.HCV coinfection is not associated with HBsAg loss. A higher ALT level is a major determinant of HBsAg loss in patients with HBV/HCV coinfection. Both HCV coinfection and a higher ALT level were independent risk factors of HCC.
More Related Videos
Related Concept Videos
Hepatitis
Cytomegalovirus Disease

